ondansetron has been researched along with Colitis, Granulomatous in 2 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Methotrexate (MTX) is an effective treatment for Crohn disease (CD); however, its application may be limited by the occurrence of nausea." | 7.77 | Short-course ondansetron for the prevention of methotrexate-induced nausea in children with Crohn disease. ( Barkey, J; Benchimol, EI; Boland, M; Kempinska, A; Mack, A; Mack, DR, 2011) |
| "Methotrexate (MTX) is an effective treatment for Crohn disease (CD); however, its application may be limited by the occurrence of nausea." | 3.77 | Short-course ondansetron for the prevention of methotrexate-induced nausea in children with Crohn disease. ( Barkey, J; Benchimol, EI; Boland, M; Kempinska, A; Mack, A; Mack, DR, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gomollón, F | 1 |
| Rubio, S | 1 |
| Charro, M | 1 |
| García-López, S | 1 |
| Muñoz, F | 1 |
| Gisbert, JP | 1 |
| Domènech, E | 1 |
| Kempinska, A | 1 |
| Benchimol, EI | 1 |
| Mack, A | 1 |
| Barkey, J | 1 |
| Boland, M | 1 |
| Mack, DR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Ondansetron Premedication Trial in Juvenile Idiopathic Arthritis[NCT04169828] | 176 participants (Anticipated) | Interventional | 2019-08-02 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for ondansetron and Colitis, Granulomatous
| Article | Year |
|---|---|
[Reccomendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of methotrexate in inflammatory bowel disease].
Topics: Adult; Antiemetics; Antirheumatic Agents; Bone Marrow Diseases; Chemical and Drug Induced Liver Inju | 2015 |
Short-course ondansetron for the prevention of methotrexate-induced nausea in children with Crohn disease.
Topics: Adolescent; Case-Control Studies; Child; Crohn Disease; Dose-Response Relationship, Drug; Female; Hu | 2011 |